ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025

Stock Information for ImmuCell Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ImmuCell Corporation

ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025
ImmuCell Announces Onboarding of New CEO and Related Management Changes
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025
ImmuCell Announces Selection of its Next President and CEO
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.